Planipart Solution for Injection 30 microgram/ml

País: Irlanda

Idioma: anglès

Font: HPRA (Health Products Regulatory Authority)

Compra'l ara

Fitxa tècnica Fitxa tècnica (SPC)
12-06-2017

ingredients actius:

Clenbuterol hydrochloride

Disponible des:

Boehringer Ingelheim Ltd

Codi ATC:

QG02CA91

Designació comuna internacional (DCI):

Clenbuterol hydrochloride

Dosis:

30 microgram(s)/millilitre

formulario farmacéutico:

Solution for injection

tipo de receta:

VPO: Veterinary Practitioner Only as defined in relevant national legislation

Grupo terapéutico:

Cattle

Área terapéutica:

clenbuterol

indicaciones terapéuticas:

Miscellaneous

Estat d'Autorització:

Authorised

Data d'autorització:

1989-10-01

Fitxa tècnica

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Planipart Solution for Injection 30 microgram/ml.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
Active substance:
Clenbuterol hydrochloride
30 micrograms
Excipients:
Benzyl alcohol
10 mg
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
Pale yellow, clear solution for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
To relax the uterus in cattle, usually at the time of parturition.
In particular:
1.
In heifers to delay delivery to allow full preparation of the soft
birth canal.
2.
As an aid to obstetrical manoeuvres in dystocia, e.g. malpresentation
and malposture.
3.
To relax the uterus for Caesarean section.
4.
To delay and therefore programme delivery to permit observation of
parturition, e.g. avoidance of night time delivery.
5.
To facilitate the replacement of prolapsed uterus.
6.
In embryo transfer technique to ensure less traumatic manipulation of
the uterus.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active
ingredient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The earlier in the stage of labour that treatment is given, the longer
will be the period of abolition of uterine
contraction.
Once the cervix is fully diilated or the foetal feet are passing into
the cervical area, the product will only
delay parturition for a maxiumum of a few hours.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
__
                                
                                Llegiu el document complet
                                
                            

Cerqueu alertes relacionades amb aquest producte